1
Home
Companies

Aviragen Therapeutics

Aviragen Therapeutics
Leadership team

Barbara G. Duncan (Independent Director)

Franklin M. Berger (Lead Independent Director)

Jean-Pierre Sommadossi (Founder, Chairman, CEO & President)

Products/ Services
Biotechnology
Number of Employees
0 - 50
Headquarters
Melbourne, Victoria, Australia
Established
1984
Company Registration
SEC CIK number: 0001593899
Traded as
NASDAQ:AVIR
Social Media
URL
www.aviragentherapeutics.com/
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
Aviragen Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of direct-acting antivirals to treat infections that affect a number of patient populations in the United States and internationally.
History

Aviragen Therapeutics, Inc. is a clinical-stage biopharmaceutical company that was incorporated in Delaware in 2008.We focus on the discovery and development of direct-acting antivirals to treat infections that affect a number of patient populations in the United States and internationally. Based in Alpharetta, Georgia, we are a worldwide organization with offices in the United States, United Kingdom and Germany.

Mission
To be a leader in the discovery and development of antiviral therapeutics.
Vision
To create innovative and effective antiviral therapies for patients in need and to make a significant contribution to research and pharmaceutical development of viral diseases.
Key Team

Bruce Polsky (Independent Director)

Bruno Lucidi (Independent Director)

Polly A. Murphy (Independent Director)

Jerome M. Adams (Independent Director)

Recognition and Awards
Aviragen Therapeutics, Inc. has been recognized by institutions such as the Association of Biotechnology Companies, BioFlorida, and the Small Business Technology Council, as well as nationally renowned organizations such as the National Institutes of Health and the Centers for Disease Control and Prevention.
References

https://in.investing.com/equities/atea-pharmaceuticals-inc

https://www.crunchbase.com/organization/biota-pharmaceuticals-inc

www.aviragentherapeutics.com/

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Aviragen Therapeutics
Leadership team

Barbara G. Duncan (Independent Director)

Franklin M. Berger (Lead Independent Director)

Jean-Pierre Sommadossi (Founder, Chairman, CEO & President)

Products/ Services
Biotechnology
Number of Employees
0 - 50
Headquarters
Melbourne, Victoria, Australia
Established
1984
Company Registration
SEC CIK number: 0001593899
Traded as
NASDAQ:AVIR
Social Media
URL
www.aviragentherapeutics.com/